C A R E CHEMOTHERAPY ANTIEMETIC REGIMENEVALUATION

Welcome to the Brand page for “C A R E CHEMOTHERAPY ANTIEMETIC REGIMENEVALUATION”, which is offered here for Computer software for the healthcare industry that monitors cancer patients' outcome to antiemetics and the cost associated with these outcomes, and instructional manuals, sold together as a unit;care chemotherapy antiemetic regimen evaluation;chemotherapy antiemetic regimen evaluation;the stippling shown in the drawing is a feature of the mark and is not intended to indicate color.;.

Its status is currently believed to be active. Its class is unavailable. “C A R E CHEMOTHERAPY ANTIEMETIC REGIMENEVALUATION” is believed to be currently owned by “SMITHKLINE BEECHAM CORPORATION”.


Owner:
SMITHKLINE BEECHAM CORPORATION
Owner Details
Description:
Computer software for the healthcare industry that monitors cancer patients' outcome to antiemetics and the cost associated with these outcomes, and instructional manuals, sold together as a unit;CARE CHEMOTHERAPY ANTIEMETIC REGIMEN EVALUATION;CHEMOTHERAPY ANTIEMETIC REGIMEN EVALUATION;The stippling shown in the drawing is a feature of the mark and is not intended to indicate color.;
Categories: COMPUTER SOFTWARE HEALTHCARE